First Two Cases of Allergic Contact Dermatitis From Isobutylamido Thiazolyl Resorcinol (‘Thiamidol’) in Depigmenting Skin Care Routine
O.A. is an investigator, consultant and/or speaker for Leo Pharma, Abbvie, Sanofi, L'Oréal/La Roche Posay and Bioderma/NAOS. J.P. is an investigator, consultant and/or speaker for Leo Pharma, Abbvie, Sanofi, Pfizer, Lilly and Almirall. A.C. is an investigator, consultant and/or speaker for Leo Pharma, Abbvie, Sanofi, Pfizer, Lilly and Almirall. The other authors declare no conflicts of interest.
Authors
- Olivier Aerts (ORCID: https://orcid.org/0000-0002-0076-2887)
- Aude Clément (ORCID: https://orcid.org/0000-0002-7769-4149)
- Justine Pasteur (ORCID: https://orcid.org/0000-0002-4766-0693)
- Ella Dendooven (ORCID: https://orcid.org/0000-0002-3489-8010)
- Laura Vernhet (ORCID: https://orcid.org/0009-0007-5263-0855)
- Lucas Belahssen
Institutions
- University of Antwerp (BE)
- Antwerp University Hospital (BE)
- Centre Hospitalier Universitaire de Clermont-Ferrand (FR)
Publication Details
- Journal
- Contact Dermatitis
- Published
- 2025-03-26
- DOI
- https://doi.org/10.1111/cod.14793
- Citations
- 4
- Primary Topic
- Contact Dermatitis and Allergies
- Type
- article
- Field-Weighted Citation Impact
- 8.02